Joseph L. Chin

19.5k total citations · 3 hit papers
340 papers, 11.1k citations indexed

About

Joseph L. Chin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Joseph L. Chin has authored 340 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Pulmonary and Respiratory Medicine, 96 papers in Surgery and 53 papers in Urology. Recurrent topics in Joseph L. Chin's work include Prostate Cancer Diagnosis and Treatment (159 papers), Prostate Cancer Treatment and Research (140 papers) and Bladder and Urothelial Cancer Treatments (75 papers). Joseph L. Chin is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (159 papers), Prostate Cancer Treatment and Research (140 papers) and Bladder and Urothelial Cancer Treatments (75 papers). Joseph L. Chin collaborates with scholars based in Canada, United States and United Kingdom. Joseph L. Chin's co-authors include Fred Saad, Jonathan I. Izawa, Louis Lacombe, Ian M. Thompson, Catherine M. Tangen, Edith Canby‐Hagino, Gregory P. Swanson, Jeffrey D. Forman, E. David Crawford and Edward M. Messing and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Joseph L. Chin

331 papers receiving 10.8k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

2002 1.2k citations Joseph L. Chin et al. profile →
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

2009 826 citations Ian M. Thompson, Catherine M. Tangen et al. The Journal of Urology profile →
Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

2006 664 citations Ian M. Thompson, Catherine M. Tangen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph L. Chin Canada	51	6.9k	2.9k	2.2k	1.5k	1.5k	340	11.1k
Leonard G. Gomella United States	63	6.7k 1.0×	2.6k 0.9×	2.5k 1.2×	3.4k 2.2×	1.2k 0.8×	385	12.7k
Robert Huddart United Kingdom	62	5.6k 0.8×	7.8k 2.7×	3.2k 1.5×	2.7k 1.7×	1.8k 1.2×	388	14.9k
Jason A. Efstathiou United States	49	5.0k 0.7×	4.9k 1.7×	2.3k 1.1×	1.9k 1.2×	1.1k 0.8×	314	11.4k
Robert K. Nam Canada	44	5.4k 0.8×	1.5k 0.5×	1.5k 0.7×	1.6k 1.1×	691 0.5×	165	8.7k
Paul F. Schellhammer United States	53	9.5k 1.4×	4.0k 1.4×	5.0k 2.3×	3.3k 2.2×	1.9k 1.3×	274	17.6k
Theo M. de Reijke Netherlands	40	3.7k 0.5×	2.6k 0.9×	969 0.4×	1.3k 0.9×	631 0.4×	189	7.5k
Anthony L. Zietman United States	66	10.6k 1.5×	5.6k 1.9×	2.9k 1.3×	1.0k 0.7×	1.8k 1.3×	330	16.8k
Andrew J. Stephenson United States	51	7.7k 1.1×	3.4k 1.2×	1.2k 0.5×	1.7k 1.1×	794 0.5×	242	10.5k
David P. Wood United States	62	7.9k 1.1×	6.2k 2.2×	2.7k 1.3×	2.1k 1.4×	768 0.5×	281	14.8k
Steven Joniau Belgium	59	14.5k 2.1×	3.4k 1.2×	2.9k 1.3×	3.1k 2.0×	3.0k 2.0×	458	18.7k

Countries citing papers authored by Joseph L. Chin

Since Specialization

Citations

This map shows the geographic impact of Joseph L. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Chin more than expected).

Fields of papers citing papers by Joseph L. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph L. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Chin. The network helps show where Joseph L. Chin may publish in the future.

Co-authorship network of co-authors of Joseph L. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph L. Chin. A scholar is included among the top collaborators of Joseph L. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph L. Chin. Joseph L. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sutherland, Duncan E. K., Glenn Bauman, Brandon Driscoll, et al.. (2024). 18F-DCFPyL in the Detection of Prostate Cancer Spread to the Lumbosacral Plexus. Clinical Nuclear Medicine. 50(4). e232–e233. 1 indexed citations

Kwak, Lucia, Praful Ravi, John G. Armstrong, et al.. (2024). Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of Clinical Oncology. 42(18). 2132–2138. 6 indexed citations

Kulkarni, Girish S., Kyle A. Richards, Peter C. Black, et al.. (2023). MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS). The Journal of Urology. 209(Supplement 4). 3 indexed citations

Chin, Joseph L., et al.. (2023). A Canadian center’s experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities. Canadian Urological Association Journal. 17(12). 1 indexed citations

Power, Nicholas, et al.. (2022). Artificial intelligence for prostate cancer histopathology diagnostics. Canadian Urological Association Journal. 16(12). 439–441. 2 indexed citations

Halstuch, Daniel, et al.. (2021). A Randomized Controlled Trial of a Modified Cystoscopy Technique using the Peak-End Rule in order to Improve Pain and Anxiety. Urology. 154. 33–39. 5 indexed citations

Elterman, Dean, William Li, Gencay Hatiboglu, et al.. (2020). Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia. Journal of Endourology. 35(4). 497–505. 11 indexed citations

Chin, Joseph L., Glenn Bauman, Nicholas Power, & Aaron D. Ward. (2020). The Singularity is Near(ish): Emerging Applications of Artificial Intelligence in Prostate Cancer Management. European Urology. 77(3). 293–295. 4 indexed citations

Fervaha, Gagan, Jason Izard, Dean A. Tripp, et al.. (2020). Psychological morbidity associated with prostate cancer: Rates and predictors of depression in the RADICAL PC study. Canadian Urological Association Journal. 15(6). 181–186. 12 indexed citations

10.

Billia, Michele, Khurram Siddiqui, Li Fan, et al.. (2016). Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound. Canadian Urological Association Journal. 10(11-12). 416–416. 3 indexed citations

11.

Palmer, Trenis D., Carlos H. Martínez, Katie E. Hebron, et al.. (2013). Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression. Cancer Research. 74(1). 173–187. 40 indexed citations

12.

Ahmed, Hashim U., Paul Cathcart, Venu Chalasani, et al.. (2011). Whole‐gland salvage high‐intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy. Cancer. 118(12). 3071–3078. 45 indexed citations

13.

Chin, Joseph L., John R. Srigley, R. Bryan Rumble, et al.. (2010). Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management:evidentiary base. Canadian Urological Association Journal. 4(1). 13–25. 25 indexed citations

14.

Xuan, Jim W., Hongyi Jiang, Fatma Valiyeva, et al.. (2007). Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound. Cancer Research. 67(6). 2830–2839. 50 indexed citations

15.

Swanson, Gregory P., Michael A. Hussey, Catherine M. Tangen, et al.. (2007). Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794. Journal of Clinical Oncology. 25(16). 2225–2229. 198 indexed citations

16.

Izawa, Jonathan I., Joseph L. Chin, & Eric Winquist. (2006). Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.. PubMed. 13 Suppl 3. 48–53. 6 indexed citations

17.

Chin, Joseph L.. (2006). From retrograde pyelography to robotic prostatectomy: history of urology at the University of Western Ontario.. PubMed. 13(1). 2949–52. 1 indexed citations

18.

Xuan, Jim W., Hideki Sakai, Hiroshi Kanetake, et al.. (2003). Correlation study showing no concordance between EPAS-1/HIF-2α mRNA and protein expression in transitional cellcancer of the bladder. Urology. 61(4). 851–857. 9 indexed citations

19.

Ji, Ping, Jim W. Xuan, Hideki Sakai, et al.. (2002). Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.. PubMed. 8(2). 471–80. 81 indexed citations

20.

Moussa, Madeleine, Hideki Sakai, Franky Leung Chan, et al.. (2001). Rodent PSP94 Gene Expression Is More Specific to the Dorsolateral Prostate and Less Sensitive to Androgen Ablation than Probasin¹. Endocrinology. 142(5). 2138–2146. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact